the aid library

LIST OPTIONS

Filter

7629

Challenges in management and prevention of ischemic heart disease in low socioeconomic status people in LLMICs

Gupta, R.; Yusuf, S. BMC Medicine (2019) CC

Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (... more

Download (282)

View PDF (295)

A Matter of Life and Death: Tackling Violence against Health Care in Pakistan, Peru and El Salvador

International Committee of the Red Cross (ICRC) (2017) C1

Every day, health-care providers are being attacked, patients discriminated against, ambulances held up at checkpoints, hospitals bombed, medical supplies looted and entire communities cut off from critical services around the world.
Between January 2012 and December 2014, the ICRC documented n... more

External Link

Managing Hazardous Materials Incidents (MHMI) Volume I-III (Revised)

U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry (ATSDR) (2001) C2

The Agency for Toxic Substances and Disease Registry (ATSDR) has produced a three-volume series entitled Managing Hazardous Material Incidents. The series is designed to help emergency response and health care professionals plan for and respond to hazardous material emergencies. - Volume I Emergenc... more

Download (135)

View PDF (162)

EQUINET Information sheet on COVID-19

R Loewenson EQUINET (2020) C1

Produced by Training and Research Support Centre for the Regional Network for Equity in Health in east and southern Africa (EQUINET), March 20, 2020. This brief summarises and provides links to official, scientific and other resources to support an understanding of and individual to regional level... more

Download (226)

View PDF (244)

Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection
recommended

World Health Organization WHO (2021) C_WHO

15 July 2021. This report describes the demographics, clinical presentation, clinical outcomes, and risk factors among people living with HIV (PLHIV) who have been hospitalized for suspected or confirmed COVID-19. The specific objectives of the analysis were to: describe the clinical char... more

Download (260)

View PDF (586)

Towards a Common Language for Functioning, Disability and Health: ICF (The International Classification of Functioning, Disability and Health)

World Health Organization (WHO) (2002) C_WHO

The International Classification of Functioning, Disability and Health, known more commonly as ICF, provides a standard language and framework for the description of health and health-related states. Like the first version published by the World Health Organization for trial purposes in 1980, ICF is... more

Download (180)

View PDF (201)

Nurses as substitutes for doctors in primary care - Review

Laurant M, van der Biezen M, Wijers N et al. Cochrane Library (2018) CC

Current and expected problems such as ageing, increased prevalence of chronic conditions and multi-morbidity, increased emphasison healthy lifestyle and prevention, and substitution for care from hospitals by care provided in the community encourage countries worldwide to develop new models of prima... more

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (423)

View PDF (574)

Interim Planning Guidance for Preparedness and Response to a Mass Casualty Event Resulting from Terrorist Use of Explosives

Centers for Disease Control and Prevention; US Dept. of Health and Human Services (2010) C1

The purpose of this interim guidance is to provide information and insight to assist public policy and health system leaders in preparing for and responding to an MCE caused by terrorist use of explosives (TUE). This document provides practical information to promote comprehensive mass casualty ca... more

Download (187)

View PDF (249)

Prevençãodo VIH 2025 roteiro

UNAIDS World Health Organization WHO (2022) C_WHO

No rumo certo para acabar com a SIDA como ameaca à saúde pública até 2030. This new Road Map charts a way forward for country-level actions to achieve an ambitious set of HIV prevention targets by 2025. Those targets emerged from the 2021 Political Declaration on HIV and AIDS, which the United N... more

Download (441)

View PDF (398)

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19
recommended

World Health Organization WHO (2021) C_WHO

Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident... more

Download (214)

View PDF (233)

National Multisectoral Action Plan (NMAP) for Prevention and Control of Common NCDs (2017-22)

Ministry of Health and Family Welfare Government of India; WHO (2017) C_WHO

India is experiencing rapid demographic and epidemiological transitions with NCDs causing significant disability, morbidity and mortality both in urban and rural populations and across all socioeconomic strata. According to the ICMR State Level Disease Burden Initiative, in 2016, NCDs accounted to a... more

Download (557)

View PDF (1498)

Advocacy for Family Planning: Understanding the Budget Process in Two Nigerian States - Cross River and Zamfara

Donald Dickerson and Aliyu Aminu Ahmed Health Policy Project, Futures Group (2013) C1

For several decades, civil society organisations (CSOs) in Nigeria have been advocating for increased resources for family planning (FP) and reproductive health (RH) services and commodities. To help CSOs in Nigeria understand and actively participate in the budget process at the state level, a team... more

Download (280)

View PDF (359)

MENTAL HEALTH AND INTEGRATION: PROVISION FOR SUPPORTING PEOPLE WITH MENTAL ILLNESS: A COMPARISON OF 15 ASIA-PACIFIC COUNTRIES

The Economist Intelligence Unit Limited Jannsen (2016) C1

An Economist Intelligence Unit briefing paper | The Economist Intelligence Unit (EIU) undertook a study aimed at assessing the degree of commitment of 15 countries within the AsiaPacific region to integrating those with mental illness into their communities. The research was commissioned and funded... more

Download (228)

View PDF (246)

Point-of-use fortification with micronutrient powders (mnp)improving the nutrition of infants and young children aged 6-23 months (Community Health Volunteers))

Ministry of Health, Kenya (2020) C1

The harmonized training package for Point-of-use-fortification using micronutrient powders has been developed to guide in training frontline health workers. The micronutrient powders will be distributed at the health facilities where instructions on use will be provided by Health Care Providers. Com... more

Download (232)

View PDF (189)

Prevention, identification and management of health worker infection in the context of COVID-19 (Arab Version)
recommended

World Health Organization WHO (2020) C_WHO

This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ... more

Download (148)

View PDF (184)

Vietnam: National Action Plan on Combating Drug Resistance in the period from 2013 - 2020

Ministry of Health Vietnam (2013) C2

In Vietnam, most of the examination and treatment facilities are facing with of spread of bacteria resistant to many antibiotics. The level and speed of drug resistance are increasing, at alarming level. The burden of drug resistance is increasing due to the increasing cost of treatment, prolonged t... more

Download (202)

View PDF (288)

Coronavirus SARS-CoV-2/ COVID-19 Pandemic: Information and interim guidelines for pharmacists and the pharmacy workforce

International Pharmaceutical Federation (FIP) (2020) CC

The purpose of this document is to provide relevant information and guidelines on coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a primary care context (i.e. community phar... more

Download (273)

View PDF (303)

Seniors at risk: Heat and climate change

Climate central (2020) C2

Heat is the top killer among all types of weather hazards, including hurricanes and tornadoes. But hospitals and health care providers do not always report heat-related illnesses or heat as an underlying cause of a death, making it hard to measure the actual impact of extreme heat on health.

External Link

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

GBD2019 Dementia Forecasting Coolaborators (2022) CC

Lancet Public health 2022 January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8 Growth in the number of individuals living with dementia underscores the need for public health planning efforts and policy to address the needs of this group. Country-level estimates can be used to inform nati... more

Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection recommended

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19 recommended

Prevention, identification and management of health worker infection in the context of COVID-19 (Arab Version) recommended

Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection
recommended

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19
recommended

Prevention, identification and management of health worker infection in the context of COVID-19 (Arab Version)
recommended